Skip to content
10-K

Annual Report

VBI VACCINES INC.

0001437749-16-026076

← back to feed
Filed
Feb 26, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Feb 24, 2016 25.5M sh
Capex FY 2015 · Dec 31, 2015 $77.77K
Capex FY 2015 · Dec 31, 2014 $112.33K
Long Term Debt FY 2015 · Dec 31, 2015 $1.09M
Long Term Debt restated FY 2015 · Dec 31, 2014 $1.38M
Short Term Debt FY 2015 · Dec 31, 2015 $900K
Short Term Debt FY 2015 · Dec 31, 2014 $375K
Cash And Equivalents FY 2015 · Dec 31, 2015 $7.28M
Cash And Equivalents FY 2015 · Dec 31, 2014 $12.6M
Cash And Equivalents restated FY 2015 · Dec 31, 2013 $624.42K
Stockholders Equity FY 2015 · Dec 31, 2015 $4.24M
Stockholders Equity FY 2015 · Dec 31, 2014 $10.69M
Stockholders Equity restated FY 2015 · Dec 31, 2013 −$17.23M
Current Liabilities FY 2015 · Dec 31, 2015 $3.03M
Current Liabilities FY 2015 · Dec 31, 2014 $1.59M
Total Liabilities FY 2015 · Dec 31, 2015 $4.12M
Total Liabilities restated FY 2015 · Dec 31, 2014 $2.97M
Current Assets FY 2015 · Dec 31, 2015 $7.89M
Current Assets FY 2015 · Dec 31, 2014 $13.17M
Total Assets FY 2015 · Dec 31, 2015 $8.36M
Total Assets restated FY 2015 · Dec 31, 2014 $13.7M
Rd Expense FY 2015 · Dec 31, 2015 $7.07M
Rd Expense FY 2015 · Dec 31, 2014 $3.18M
Net Income FY 2015 · Dec 31, 2015 −$13.9M
Net Income FY 2015 · Dec 31, 2014 −$14.41M
Operating Income FY 2015 · Dec 31, 2015 −$13.16M
Operating Income FY 2015 · Dec 31, 2014 −$13.16M
Revenue FY 2015 · Dec 31, 2015 $395.96K